the power of
resolution
Ventus is expanding the frontier
for structure-based drug design
For targets that are beyond
reach or underexploited,
our platform is designed to
reveal the unmarked paths to druggability. new medicines.

company
metrics

  • 1
    resolute team
  • 100s of diverse hits
    for undruggable
    targets
  • 1st company
    to solve innate
    immune protein
    structures
  • $290 million
    in financing
    raised to-date
  • Billions of compounds
    rapidly screened
    using advanced
    physics-based
    approaches
  • 4 pipeline programs
    in multiple
    therapeutic areas
  • 4 founders
    who are
    members of a
    National Academy
    of Sciences
Our resolve is to make everyday moments possible for patients.

View Our Pipeline